m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia
Aging · 30.09.2023 · 15 (18) · 9858-9876
DOI: 10.18632/aging.205059 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Aging, online erschienen am 25.09.2023. Verfasst von Ya Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Zhanjiang Institute of Clinical Medicine, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang 524045, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhanjiang Institute of Clinical Medicine, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang 524045, China.
- Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, China.
Zitieren
APA
Liu, Y., Chen, Y., Cai, M., Hong, Y., Wu, X., & Li, S. (2023). m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia. Aging, 15(18), 9858-9876. https://doi.org/10.18632/aging.205059
Vancouver
Liu Y, Chen Y, Cai M, Hong Y, Wu X, Li S. m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia. Aging. 2023;15(18):9858-9876. doi:10.18632/aging.205059
BibTeX
@article{Liu2023,
author = {Liu, Ya and Chen, Yiying and Cai, Maoping and Hong, Yunguang and Wu, Xiang and Li, Songyu},
title = {m5C methylation modification guides the prognostic value and immune landscapes in acute myeloid leukemia},
journal = {Aging},
year = {2023},
volume = {15},
number = {18},
pages = {9858--9876},
doi = {10.18632/aging.205059}
}
EUVIMED